During the past decade, Rochester Skin Lymphoma Medical Group conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rochester Skin Lymphoma Medical Group" #1 collaborator was "Rochester General Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rochester Skin Lymphoma Medical Group" are "Cutaneous T-Cell Lymphoma/Mycosis Fungoides" (2 trials), "Cutaneous T-Cell Lymphoma" (1 trials), "Cutaneous T-cell Lymphoma" (1 trials), "Cutaneous T-cell Lymphoma Stage I" (1 trials) and "Folliculotropic Mycosis Fungoides" (1 trials). Many other conditions were trialed in "Rochester Skin Lymphoma Medical Group" in a lesser frequency.

Most popular intervention types in "Rochester Skin Lymphoma Medical Group" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Cobomarsen" (1 trials), "Decitabine + Cedazuridine" (1 trials), "Hypericin" (1 trials), "Placebo" (1 trials) and "SGX301 (synthetic hypericin)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rochester Skin Lymphoma Medical Group" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Rochester Skin Lymphoma Medical Group". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Rochester Skin Lymphoma Medical Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rochester Skin Lymphoma Medical Group, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".